Rep. Julie Johnson Sells Cigna Group (NYSE:CI) Stock

Representative Julie Johnson (D-Texas) recently sold shares of Cigna Group (NYSE:CI). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cigna Group stock on December 18th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Philip Morris International (NYSE:PM) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Bank of America (NYSE:BAC) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 12/18/2025.
• Sold $1,001 – $15,000 in shares of Republic Services (NYSE:RSG) on 12/18/2025.

Cigna Group Stock Down 2.0%

NYSE:CI traded down $5.65 during mid-day trading on Friday, hitting $272.29. The company had a trading volume of 1,702,227 shares, compared to its average volume of 1,320,979. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The business has a fifty day simple moving average of $273.63 and a 200-day simple moving average of $287.08. The firm has a market capitalization of $72.74 billion, a price-to-earnings ratio of 12.01, a PEG ratio of 0.96 and a beta of 0.26.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Institutional Trading of Cigna Group

A number of hedge funds and other institutional investors have recently made changes to their positions in CI. Massachusetts Financial Services Co. MA lifted its holdings in Cigna Group by 1.1% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after purchasing an additional 123,479 shares during the last quarter. Dodge & Cox lifted its stake in shares of Cigna Group by 4.0% in the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after acquiring an additional 354,615 shares during the last quarter. Sanders Capital LLC raised its stake in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after acquiring an additional 35,150 shares during the last quarter. Valeo Financial Advisors LLC raised its holdings in Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the last quarter. Finally, Norges Bank acquired a new stake in Cigna Group during the 2nd quarter worth about $1,110,426,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on CI shares. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Robert W. Baird cut their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Mizuho set a $325.00 price target on Cigna Group in a research note on Friday, January 9th. Morgan Stanley restated an “overweight” rating and issued a $355.00 price objective on shares of Cigna Group in a research note on Friday, October 31st. Finally, Barclays upped their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “overweight” rating in a research note on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $330.48.

Insider Transactions at Cigna Group

In related news, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.70% of the stock is currently owned by corporate insiders.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.